← Back to Search

Artificial Tears

Altaire Gel forming solution for Dry Eye Syndrome

Phase 4
Waitlist Available
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Summary

The purpose of this study is to evaluate and compare the effects of Altaire Gel forming solution and Refresh Tears in mild-moderate dry eye patients.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Conjunctival and Corneal staining
TBUT

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Altaire Gel forming solutionActive Control1 Intervention
Group II: Refresh TearsPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,528 Total Patients Enrolled
~7 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top